714 related articles for article (PubMed ID: 24310455)
1. Mass lesions in the brain: tumor or multiple sclerosis? Clinical and imaging characteristics and course from a single reference center.
Kilic AK; Kurne AT; Oguz KK; Soylemezoglu F; Karabudak R
Turk Neurosurg; 2013; 23(6):728-35. PubMed ID: 24310455
[TBL] [Abstract][Full Text] [Related]
2. Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study.
Altintas A; Petek B; Isik N; Terzi M; Bolukbasi F; Tavsanli M; Saip S; Boz C; Aydin T; Arici-Duz O; Ozer F; Siva A
Mult Scler; 2012 Oct; 18(10):1448-53. PubMed ID: 22419670
[TBL] [Abstract][Full Text] [Related]
3. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
Kiriyama T; Kataoka H; Taoka T; Tonomura Y; Terashima M; Morikawa M; Tanizawa E; Kawahara M; Furiya Y; Sugie K; Kichikawa K; Ueno S
J Neuroimaging; 2011 Apr; 21(2):e69-77. PubMed ID: 20572907
[TBL] [Abstract][Full Text] [Related]
4. Distinguishing tumefactive demyelinating lesions from glioma or central nervous system lymphoma: added value of unenhanced CT compared with conventional contrast-enhanced MR imaging.
Kim DS; Na DG; Kim KH; Kim JH; Kim E; Yun BL; Chang KH
Radiology; 2009 May; 251(2):467-75. PubMed ID: 19261924
[TBL] [Abstract][Full Text] [Related]
5. Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patients.
Lebrun C; Bensa C; Debouverie M; Wiertlevski S; Brassat D; de Seze J; Rumbach L; Pelletier J; Labauge P; Brochet B; Tourbah A; Clavelou P;
Arch Neurol; 2009 Jul; 66(7):841-6. PubMed ID: 19597085
[TBL] [Abstract][Full Text] [Related]
6. Benign course of tumour-like multiple sclerosis. Report of five cases and literature review.
Turatti M; Gajofatto A; Bianchi MR; Ferrari S; Monaco S; Benedetti MD
J Neurol Sci; 2013 Jan; 324(1-2):156-62. PubMed ID: 23151425
[TBL] [Abstract][Full Text] [Related]
7. Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy.
Malhotra HS; Jain KK; Agarwal A; Singh MK; Yadav SK; Husain M; Krishnani N; Gupta RK
Mult Scler; 2009 Feb; 15(2):193-203. PubMed ID: 19181773
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of tumefactive demyelinating lesions and differential features for multiple sclerosis in etiology.
Saridas F; Mesut G; Ceylan CY; Ozpar R; Ozsen M; Koc ER; Tolunay S; Hakyemez B; Turan OF
Mult Scler Relat Disord; 2024 May; 85():105537. PubMed ID: 38460252
[TBL] [Abstract][Full Text] [Related]
9. Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
Mabray MC; Cohen BA; Villanueva-Meyer JE; Valles FE; Barajas RF; Rubenstein JL; Cha S
AJR Am J Roentgenol; 2015 Nov; 205(5):1075-85. PubMed ID: 26496556
[TBL] [Abstract][Full Text] [Related]
10. Conventional and advanced magnetic resonance imaging in tumefactive demyelination.
Saini J; Chatterjee S; Thomas B; Kesavadas C
Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739
[TBL] [Abstract][Full Text] [Related]
11. Tumefactive demyelinating lesions: a retrospective cohort study in Thailand.
Ongphichetmetha T; Aungsumart S; Siritho S; Apiwattanakul M; Tanboon J; Rattanathamsakul N; Prayoonwiwat N; Jitprapaikulsan J
Sci Rep; 2024 Jan; 14(1):1426. PubMed ID: 38228919
[TBL] [Abstract][Full Text] [Related]
12. Demyelinating lesions in the cervical cord in multiple sclerosis 10 years after onset of the disease. Correlation between MRI parameters and clinical course.
Bonek R; Orlicka K; Maciejek Z
Neurol Neurochir Pol; 2007; 41(3):229-33. PubMed ID: 17629816
[TBL] [Abstract][Full Text] [Related]
13. Isolated tumefactive demyelinating lesions: diagnosis and long-term evolution of 16 patients in a multicentric study.
Siri A; Carra-Dalliere C; Ayrignac X; Pelletier J; Audoin B; Pittion-Vouyovitch S; Debouverie M; Lionnet C; Viala F; Sablot D; Brassat D; Ouallet JC; Ruet A; Brochet B; Taillandier L; Bauchet L; Derache N; Defer G; Cabre P; de Seze J; Lebrun Frenay C; Cohen M; Labauge P
J Neurol; 2015 Jul; 262(7):1637-45. PubMed ID: 25929666
[TBL] [Abstract][Full Text] [Related]
14. Tumour-like lesions in multiple sclerosis.
Jamroz-Wiśniewska A; Janczarek M; Belniak E; Stelmasiak Z; Bartosik-Psujek H
Neurol Neurochir Pol; 2008; 42(2):161-7. PubMed ID: 18512174
[TBL] [Abstract][Full Text] [Related]
15. Tumefactive demyelinating lesions: A comprehensive review.
Algahtani H; Shirah B; Alassiri A
Mult Scler Relat Disord; 2017 May; 14():72-79. PubMed ID: 28619436
[TBL] [Abstract][Full Text] [Related]
16. Clinical isolated syndrome: a 3-year follow-up study in China.
Liu Y; Duan Y; Yu C; Qin W; Chen H; Dong H; Ye J; Butzkueven H; Li K
Clin Neurol Neurosurg; 2011 Oct; 113(8):658-60. PubMed ID: 21680087
[TBL] [Abstract][Full Text] [Related]
17. Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis.
Dalton CM; Bodini B; Samson RS; Battaglini M; Fisniku LK; Thompson AJ; Ciccarelli O; Miller DH; Chard DT
Mult Scler; 2012 Mar; 18(3):322-8. PubMed ID: 21878451
[TBL] [Abstract][Full Text] [Related]
18. [The clinical features, neuroimaging findings and pathological characteristics of 26 patients with pathologically proven tumor-like inflammatory demyelinating diseases].
Qi XK; Liu JG; Qian HR; Qiu F; Yao S; Li CQ; Wang YM
Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):750-3. PubMed ID: 21092444
[TBL] [Abstract][Full Text] [Related]
19. Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.
Lucchinetti CF; Gavrilova RH; Metz I; Parisi JE; Scheithauer BW; Weigand S; Thomsen K; Mandrekar J; Altintas A; Erickson BJ; König F; Giannini C; Lassmann H; Linbo L; Pittock SJ; Brück W
Brain; 2008 Jul; 131(Pt 7):1759-75. PubMed ID: 18535080
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of acute partial transverse myelitis.
Bourre B; Zéphir H; Ongagna JC; Cordonnier C; Collongues N; Debette S; Fleury MC; Outteryck O; Hannequin D; Vermersch P; de Seze J
Arch Neurol; 2012 Mar; 69(3):357-62. PubMed ID: 22410443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
